Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
Mahbuba Akther, Md. Ezazul Haque, Jooho Park, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8780-8780
Open Access | Times Cited: 66

Showing 26-50 of 66 citing articles:

The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders
Jiayue Li, Li Li, Jiannan He, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 12
The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases
Mina Dadkhah, Mohammadreza Sharifi
International Reviews of Immunology (2024) Vol. 44, Iss. 2, pp. 98-111
Closed Access | Times Cited: 4
Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
Doris Loh, Rüssel J. Reiter
Molecules (2022) Vol. 27, Iss. 3, pp. 705-705
Open Access | Times Cited: 17
Ubiquitination is a major modulator for the activation of inflammasomes and pyroptosis
Qiuyun Jiang, Zhigang Zhu, Xinliang Mao
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1866, Iss. 3, pp. 194955-194955
Closed Access | Times Cited: 10
Neural Stem Cell Extracellular Vesicles Carrying YBX1 Inhibited Neuronal Pyroptosis Through Increasing m6A-modified GPR30 Stability and Expression in Ischemic Stroke
Jun Peng, Jun He, Long Lin, et al.
Translational Stroke Research (2023)
Closed Access | Times Cited: 10
NLRP3 Regulates Mandibular Healing through Interaction with UCHL5 in MSCs
Wenhua Zhao, Yanan Cao, Yue Chen, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 3, pp. 936-949
Open Access | Times Cited: 9
The roles of ubiquitination and deubiquitination of NLRP3 inflammasome in inflammation-related diseases: A review
Shaokai Tang, Yuanwen Geng, Yawei Wang, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 4, pp. 708-721
Open Access | Times Cited: 3
TRIM59 suppresses the brain ischaemia/reperfusion injury and pyroptosis of microglial through mediating the ubiquitination of NLRP3
Liangtian Zhang, Gang� Li, Ying Li
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Activation of the NLRP3-CASP-1 inflammasome is restrained by controlling autophagy during Glaesserella parasuis infection
Chaoxiong Yue, Jinquan Li, Siming Zhang, et al.
Veterinary Microbiology (2024) Vol. 295, pp. 110160-110160
Closed Access | Times Cited: 3
Regulation of NLRPs by reactive oxygen species: A story of crosstalk
Bjoern Ziehr, Justin A. MacDonald
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 8, pp. 119823-119823
Open Access | Times Cited: 3
NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically
Ainara González-Moro, Inés Valencia, Licia Shamoon, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 269-269
Open Access | Times Cited: 14
Focus on the role of NLRP3 inflammasome in the pathology of endometriosis: a review on molecular mechanisms and possible medical applications
Elnaz Irandoost, Shaparak Najibi, Saba Talebbeigi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 4, pp. 621-631
Closed Access | Times Cited: 14
Vitamin D3 attenuates SARS‐CoV‐2 nucleocapsid protein‐caused hyperinflammation by inactivating the NLRP3 inflammasome through the VDR‐BRCC3 signaling pathway in vitro and in vivo
Mingliang Chen, Ying He, Xiaofeng Hu, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 8
E3 ubiquitin ligase CBL-B suppresses vascular endothelial cell pyroptosis and injury in intracranial aneurysm by facilitating NLRP3 degradation
Wei Zheng, Cheng Liu
Biocell (2024) Vol. 48, Iss. 2, pp. 293-301
Open Access | Times Cited: 2
Pyroptosis of Vascular Smooth Muscle Cells as a Potential New Target for Preventing Vascular Diseases
Di Chang, Meng Ji, Wenjin Li, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 2
Harnessing Pyroptosis for Lung Cancer Therapy: The Impact of NLRP3 Inflammasome Activation
Rajiv Dahiya, Vijaykumar Sutariya, Sheeba Varghese Gupta, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155444-155444
Closed Access | Times Cited: 2
Mushroom Natural Products in Neurodegenerative Disease Drug Discovery
Arjuna Abitbol, Brody Mallard, Evelin Tiralongo, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3938-3938
Open Access | Times Cited: 12
Carrier-free quercetin nanomedicine blocks NLRP3 deubiquitination and TXNIP recruitment for Parkinson’s disease therapy
Dongju Zhao, Chao Tian, Meng Cheng, et al.
Chemical Engineering Journal (2023) Vol. 464, pp. 142697-142697
Closed Access | Times Cited: 6
VEXAS syndrome, a new kid on the block of auto-inflammatory diseases: A hematologist's point of view
Maël Heiblig, Bhavisha A. Patel, Yvan Jamilloux
Best Practice & Research Clinical Rheumatology (2023) Vol. 37, Iss. 1, pp. 101861-101861
Closed Access | Times Cited: 6
The regulatory role and mechanism of USP14 in endothelial cell pyroptosis induced by coronary heart disease
Jie Gao, Zhao Gao
Clinical Hemorheology and Microcirculation (2023) Vol. 86, Iss. 4, pp. 495-508
Closed Access | Times Cited: 6
Posttranslational Regulation of Inflammasomes, Its Potential as Biomarkers and in the Identification of Novel Drugs Targets
Sambit K. Nanda, Stefan Vollmer, Ana B. Pérez‐Oliva
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 10
Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity
Xinyi Wu, Ping Sun, Xiuhui Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 11985-12001
Closed Access | Times Cited: 10
An update on the role of TRIM/NLRP3 signaling pathway in atherosclerosis
Sibo Liu, Hongfeng Bi, Meiling Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114321-114321
Open Access | Times Cited: 5
Thiolutin attenuates ischemic stroke injury via inhibition of NLRP3 inflammasome: an in vitro and in vivo study
Yujie Jia, Xue Kun, Ying Luo, et al.
Experimental Brain Research (2023) Vol. 241, Iss. 3, pp. 839-849
Closed Access | Times Cited: 5
Multiple sclerosis: the NLRP3 inflammasome, gasdermin D, and therapeutics
Amie Brint, Seth Greene, Alyssa R Fennig-Victor, et al.
Annals of Translational Medicine (2024) Vol. 12, Iss. 4, pp. 62-62
Open Access | Times Cited: 1

Scroll to top